WO2001077384A2 - DETEKTION VON SNPs UND CYTOSIN-METHYLIERUNGEN - Google Patents
DETEKTION VON SNPs UND CYTOSIN-METHYLIERUNGEN Download PDFInfo
- Publication number
- WO2001077384A2 WO2001077384A2 PCT/IB2001/000713 IB0100713W WO0177384A2 WO 2001077384 A2 WO2001077384 A2 WO 2001077384A2 IB 0100713 W IB0100713 W IB 0100713W WO 0177384 A2 WO0177384 A2 WO 0177384A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- single nucleotide
- nucleotide polymorphisms
- oligonucleotides
- genomic dna
- detection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- the amplicates are hybridized to a set of oligonucleotides or PNA oligomers which comprise at least 10 of the above-mentioned sequences, namely the sequences SEQ-ID: 1 to SEQ-ID: 382046.
- the hybridized amplificates are detected.
- the labels attached to the amplificates can be identified at any position on the solid phase at which an oligonucleotide sequence is located.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/257,017 US20040241651A1 (en) | 2000-04-07 | 2001-04-06 | Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
EP01923891A EP1268856A2 (de) | 2000-04-07 | 2001-04-06 | Detektion von snp's und cytosin-methylierungen |
AU2001250572A AU2001250572A1 (en) | 2000-04-07 | 2001-04-06 | Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10019173 | 2000-04-07 | ||
DE10019173.8 | 2000-04-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001077384A2 true WO2001077384A2 (de) | 2001-10-18 |
WO2001077384A3 WO2001077384A3 (de) | 2002-07-25 |
Family
ID=7639166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2001/000713 WO2001077384A2 (de) | 2000-04-07 | 2001-04-06 | DETEKTION VON SNPs UND CYTOSIN-METHYLIERUNGEN |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040241651A1 (de) |
EP (1) | EP1268856A2 (de) |
AU (1) | AU2001250572A1 (de) |
WO (1) | WO2001077384A2 (de) |
Cited By (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003060160A2 (en) * | 2002-01-18 | 2003-07-24 | Genomar Asa | Verification of fish origin based on nucleic acid pattern recognition |
WO2003064700A2 (en) * | 2002-01-30 | 2003-08-07 | Epigenomics Ag | Identification of cell differentiation states based on methylation patterns |
EP1352974A1 (de) * | 2002-04-02 | 2003-10-15 | Tosoh Corporation | Oligonukleotide zum Nachweis des untypischen Mycobacteriums Mycobacterium avium und Nachweisverfahren |
WO2004006941A1 (en) * | 2002-07-17 | 2004-01-22 | Index Pharmaceuticals Ab | Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders |
EP1403384A1 (de) * | 2002-09-26 | 2004-03-31 | Stichting Researchfonds Pathologie | Verfahren zum Nachweis und zur Karakterisierung von kutanem HPV und Primer und Sonden dafür |
WO2004070020A3 (en) * | 2003-01-31 | 2004-11-11 | Monsanto Technology Llc | Glyphosate tolerant alfalfa events and methods for detection thereof |
WO2005033284A3 (en) * | 2003-10-01 | 2005-07-07 | Univ California | Compositions and methods for gene expression |
WO2005116658A3 (en) * | 2004-05-24 | 2006-05-26 | Anamar Medical Ab | Method for determining a tissue degradation process by detection of comp neoepitopes |
EP1689889A2 (de) * | 2003-12-01 | 2006-08-16 | Epigenomics AG | Verfahren und nukleinsäuren zur analyse der mit der entwicklung von prostatazellproliferationsstörungen assoziierten genexpression |
WO2007005980A2 (en) * | 2005-07-06 | 2007-01-11 | Cornell Research Foundation | Dehydrin genes and promoters from coffee |
US7297785B2 (en) * | 2004-03-24 | 2007-11-20 | United States Of America As Represented By The Secretary Of The Army | Unique chromosomal sequence of Bacillus anthracis and methods of making and using thereof including real-time PCR assays |
WO2008046911A2 (en) * | 2006-10-20 | 2008-04-24 | Exiqon A/S | Novel human micrornas associated with cancer |
US7407943B2 (en) | 2001-08-01 | 2008-08-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein B expression |
EP1365032B1 (de) * | 2002-05-21 | 2008-11-19 | MTM Laboratories AG | Marker für Lungentumore |
US7498315B2 (en) * | 2004-06-01 | 2009-03-03 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
US7511131B2 (en) * | 2002-11-13 | 2009-03-31 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
US7632824B2 (en) * | 2006-03-16 | 2009-12-15 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of Mcl-1 expression |
CN101649354A (zh) * | 2008-04-21 | 2010-02-17 | 法国国家基因中心 | 核糖核苷酸标记核酸检测 |
US7722879B2 (en) * | 2003-07-10 | 2010-05-25 | Intervet International B.V. | Babesia vaccines |
US7745595B2 (en) * | 2006-08-10 | 2010-06-29 | Medical Diagnostic Laboratories, Llc | Compositions and methods for detecting Atopobium vaginae |
US7759479B1 (en) * | 2004-09-13 | 2010-07-20 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to Gemin Genes |
US7803781B2 (en) * | 2003-02-28 | 2010-09-28 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US7807647B2 (en) * | 2004-06-01 | 2010-10-05 | Pronai Therapeutics, Inc. | Methods and compositions for cancer therapy |
EP2246422A1 (de) * | 2008-01-24 | 2010-11-03 | National Institute of Advanced Industrial Science And Technology | Polynukleotid oder analogon davon und verfahren zur genexpressionsregulierung mit dem polynukleotid oder dem analogon davon |
US7833710B2 (en) | 2005-02-14 | 2010-11-16 | Samsung Electronics Co., Ltd. | Polynucleotide associated with breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing breast cancer using the same |
US7846906B2 (en) | 2003-02-28 | 2010-12-07 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
EP2261366A1 (de) * | 2007-11-23 | 2010-12-15 | Epigenomics AG | Verfahren und Nukleinsäuren zur Analyse der Genexpression, die mit der Entwicklung von mit der prostatischen Zellproliferation assozierten Krankheiten einhergeht |
US7888324B2 (en) | 2001-08-01 | 2011-02-15 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
US7910563B2 (en) * | 2003-08-12 | 2011-03-22 | Antisense Pharma Gmbh | Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA |
EP2322656A1 (de) * | 2009-11-17 | 2011-05-18 | Centre National de la Recherche Scientifique (C.N.R.S) | Verfahren zur Diagnose von Hautkrankheiten |
AU2005229157B2 (en) * | 2004-03-31 | 2011-07-21 | Commonwealth Scientific And Industrial Research Organisation | Genes involved in plant fibre development |
US20110190370A1 (en) * | 2002-11-23 | 2011-08-04 | Isis Pharmaceuticals, Inc. | Modulation of hif1(alpha) and hif2(alpha) expression |
US8026414B2 (en) * | 2003-10-27 | 2011-09-27 | Fnp Corp., Ltd. | Molecular marker associated with CMV resistance and use thereof |
EP2390371A1 (de) * | 2007-11-30 | 2011-11-30 | Genomictree, Inc. | Diagnosekit und Chip für Blasenkrebs mit blasenkrebsspezifischem Methylierungsmarkergen |
US8088914B2 (en) | 2004-04-13 | 2012-01-03 | The Rockefeller University | MicroRNA and methods for inhibiting same |
WO2012017210A1 (en) * | 2010-08-04 | 2012-02-09 | Touchlight Genetics Limited | Production of closed linear dna using a palindromic sequence |
EP2431473A1 (de) * | 2005-09-16 | 2012-03-21 | Monsanto Technology LLC | Verfahren zur genetischen Kontrolle von Insektenplagen bei Pflanzen und Zusammensetzungen dafür |
US8188255B2 (en) | 2006-10-20 | 2012-05-29 | Exiqon A/S | Human microRNAs associated with cancer |
AU2008255238B2 (en) * | 2002-05-06 | 2012-06-28 | Genesis Research And Development Corporation Limited | Compositions isolated from forage grasses and methods for their use |
US8277414B2 (en) | 2004-05-28 | 2012-10-02 | Cilag Gmbh International | Injection device |
US8313463B2 (en) | 2004-05-28 | 2012-11-20 | Cilag Gmbh International | Injection device |
US8313465B2 (en) | 2004-05-28 | 2012-11-20 | Cilag Gmbh International | Injection device |
US8313464B2 (en) | 2004-05-28 | 2012-11-20 | Cilag Gmbh International | Injection device |
US8367628B2 (en) | 2005-12-01 | 2013-02-05 | Pronai Therapeutics, Inc. | Amphoteric liposome formulation |
WO2013043817A1 (en) | 2011-09-20 | 2013-03-28 | Isis Phamaceuticals, Inc. | Antisense modulation of gcgr expression |
WO2013095119A1 (en) * | 2011-12-14 | 2013-06-27 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws | Identification of poliovirus strains |
EP2640858A2 (de) * | 2010-11-15 | 2013-09-25 | Exact Sciences Corporation | Methylierungsassay |
US8669056B2 (en) | 2002-12-31 | 2014-03-11 | Cargill Incorporated | Compositions, methods, and systems for inferring bovine breed |
US8815599B2 (en) | 2004-06-01 | 2014-08-26 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
WO2014135331A1 (en) * | 2013-03-08 | 2014-09-12 | Progenika Biopharma S.A. | Discrimination of blood type variants |
US8834419B2 (en) | 2008-06-19 | 2014-09-16 | Cilag Gmbh International | Reusable auto-injector |
US8845594B2 (en) | 2008-06-19 | 2014-09-30 | Cilag Gmbh International | Auto-injector with filling means |
US8916694B2 (en) | 2004-05-05 | 2014-12-23 | Genzyme Corporation | SNPs of apolipoprotein B and modulation of their expression |
US8939958B2 (en) | 2008-06-19 | 2015-01-27 | Cilag Gmbh International | Fluid transfer assembly for a syringe |
US8946510B2 (en) | 2004-04-09 | 2015-02-03 | Monsanto Technology Llc | Compositions and methods for control of insect infestations in plants |
US8968236B2 (en) | 2005-04-06 | 2015-03-03 | Cilag Gmbh International | Injection device |
WO2015028807A1 (en) * | 2013-08-30 | 2015-03-05 | The Secretary Of State For Health | Assay for the detection of infection-causing e. coli strains |
US9028451B2 (en) | 2006-06-01 | 2015-05-12 | Cilag Gmbh International | Injection device |
US9028453B2 (en) | 2008-06-19 | 2015-05-12 | Cilag Gmbh International | Reusable auto-injector |
US9045754B2 (en) | 2006-05-05 | 2015-06-02 | Isis Pharmaceuticals, Inc. | Short antisense compounds with gapmer configuration |
US9072833B2 (en) | 2006-06-01 | 2015-07-07 | Cilag Gmbh International | Injection device |
US9109250B2 (en) | 2009-01-30 | 2015-08-18 | Vanessa Hill | Production of closed linear DNA |
US9107933B2 (en) | 2009-03-16 | 2015-08-18 | Isis Pharmaceuticals, Inc. | Compositions and methods of targeting apolipoprotein B for the reduction of apolipoprotein C-III |
US20160138023A1 (en) * | 2009-02-12 | 2016-05-19 | Curna, Inc. | Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
US9347061B2 (en) | 2007-03-24 | 2016-05-24 | Genzyme Corporation | Administering antisense oligonucleotides complementary to human apolipoprotein B |
AU2014200037B2 (en) * | 2006-10-10 | 2016-06-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
US9358346B2 (en) | 2005-08-30 | 2016-06-07 | Cilag Gmbh International | Needle assembly for a prefilled syringe system |
US20160160216A1 (en) * | 2013-06-14 | 2016-06-09 | Deutsches Krebsforschungszentrum | Ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention |
JPWO2014034952A1 (ja) * | 2012-09-03 | 2016-08-08 | 国立大学法人九州大学 | がんに対する免疫療法の有効性の予測方法 |
AU2014277739B2 (en) * | 2005-09-16 | 2017-02-02 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
EP3058098A4 (de) * | 2013-10-18 | 2017-03-22 | Institut de Cardiologie de Montréal | Genotypisierungstests und verfahren zur beurteilung von plasmakreatin-kinasepegeln |
WO2017079266A1 (en) * | 2015-11-02 | 2017-05-11 | Monsanto Technology Llc | Cotton transgenic event mon 88702 and methods for detection and uses thereof |
US9649441B2 (en) | 2005-04-06 | 2017-05-16 | Cilag Gmbh International | Injection device (bayonet cap removal) |
US9675757B2 (en) | 2004-05-28 | 2017-06-13 | Cilag Gmbh International | Injection device |
US9675758B2 (en) | 2004-05-28 | 2017-06-13 | Cilag Gmbh International | Injection device |
EP3017044A4 (de) * | 2013-07-02 | 2017-06-14 | Ionis Pharmaceuticals, Inc. | Modulatoren des wachstumshormonrezeptors |
US9682194B2 (en) | 2008-06-19 | 2017-06-20 | Cilag Gmbh International | Re-useable auto-injector with filling means |
US9731080B2 (en) | 2005-04-06 | 2017-08-15 | Cilag Gmbh International | Injection device |
US9757520B2 (en) | 2006-06-01 | 2017-09-12 | Cilag Gmbh International | Injection device |
US9770558B2 (en) | 2005-09-27 | 2017-09-26 | Cilag Gmbh International | Auto-injection device with needle protecting cap having outer and inner sleeves |
EP2663658B1 (de) * | 2011-01-12 | 2017-10-25 | Abbott Molecular Inc. | Materialen und verfahren zum nachweis von cytomegalovirus (cmv) |
WO2017214397A1 (en) * | 2016-06-08 | 2017-12-14 | University Of Iowa Research Foundation | Compositions and methods for detecting predisposition to cardiovascular disease |
US20170356052A1 (en) * | 2014-11-18 | 2017-12-14 | Blueprint Medicines Corporation | Prkacb fusions |
US9895493B2 (en) | 2004-05-28 | 2018-02-20 | Cilag Gmbh International | Injection device |
US20180073022A1 (en) * | 2010-11-17 | 2018-03-15 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
US9994855B2 (en) | 2014-05-01 | 2018-06-12 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating growth hormone receptor expression |
US9994918B2 (en) * | 2010-05-25 | 2018-06-12 | National University Of Ireland, Galway | Diagnostic method |
NO20170739A1 (en) * | 2017-05-04 | 2018-11-05 | Patogen As | Novel virus in Fish and Method for detection |
WO2018220385A1 (en) * | 2017-05-31 | 2018-12-06 | Blue Genomics Chile Spa. | Genetic identification of piscirickettsia salmonis resistant salmonids |
WO2018209182A3 (en) * | 2017-05-11 | 2018-12-20 | The Research Foundation For The State University Of New York | Compositions and methods for loading extracellular vesicles with chemical and biological agents/molecules |
WO2019233921A1 (en) * | 2018-06-05 | 2019-12-12 | F. Hoffmann-La Roche Ag | Oligonucleotides for modulating atxn2 expression |
US10689635B2 (en) | 2011-10-17 | 2020-06-23 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US10709849B2 (en) | 2013-06-11 | 2020-07-14 | Cilag Gmbh International | Guide for an injection device |
EP3693465A1 (de) * | 2019-02-05 | 2020-08-12 | Pharmaq AS | Neuartiger fisch-coronavirus |
US10799646B2 (en) | 2013-06-11 | 2020-10-13 | Cilag Gmbh International | Injection device |
WO2021165828A1 (en) * | 2020-02-17 | 2021-08-26 | 3M Innovative Properties Company | Loop-mediated isothermal amplification primers for vibrio parahaemolyticus detection and uses thereof |
US11123492B2 (en) | 2013-06-11 | 2021-09-21 | Cilag Gmbh International | Injection device |
WO2021191369A1 (en) * | 2020-03-27 | 2021-09-30 | Precision For Medicine Gmbh | Cbx6 as epigenetic marker for the identification of immune cells, in particular memory b cells |
US11173255B2 (en) | 2013-06-11 | 2021-11-16 | Cilag Gmbh International | Injection device |
US11230712B2 (en) | 2017-11-09 | 2022-01-25 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing SNCA expression |
WO2022016222A1 (en) * | 2020-07-22 | 2022-01-27 | The Florey Institute Of Neuroscience And Mental Health | Compositions and methods for treating disorders associated with loss-of-function mutations in scn2a |
US11286485B2 (en) | 2019-04-04 | 2022-03-29 | Hoffmann-La Roche Inc. | Oligonucleotides for modulating ATXN2 expression |
US11359197B2 (en) | 2018-01-12 | 2022-06-14 | Bristol-Myers Squibb Company | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
US20220243200A1 (en) * | 2013-03-14 | 2022-08-04 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating tau expression |
EP3794124A4 (de) * | 2018-05-18 | 2022-08-10 | Olipass Corporation | Matrix-metalloproteinase-1-antisense-oligonukleotide |
US11547718B2 (en) | 2018-11-14 | 2023-01-10 | Ionis Pharmaceuticals, Inc. | Modulators of FOXP3 expression |
US11666595B2 (en) | 2016-10-07 | 2023-06-06 | Secarna Pharmaceuticals Gmbh & Co. Kg | Antisense oligonucleotides for inhibition of PD-L1 expression and treating cancer |
RU2802418C2 (ru) * | 2018-05-18 | 2023-08-28 | Олипасс Корпорейшн | Антисмысловые олигонуклеотиды матриксной металлопротеиназы-1 |
JP7386507B2 (ja) | 2019-08-02 | 2023-11-27 | 国立大学法人信州大学 | 筋分化促進剤および筋分化促進方法および筋分化促進オリゴdna |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262249B1 (en) * | 1998-06-23 | 2001-07-17 | Chiron Corporation | Pancreatic cancer genes |
DE10048091A1 (de) * | 2000-09-28 | 2002-04-25 | Ernst Bayer | Anwendung chemisch modifizierter Oligodesoxyribonukleotide zur Unterdrückung der Proliferation von humanem Pankreastumor |
US7612194B2 (en) * | 2001-07-24 | 2009-11-03 | Monsanto Technology Llc | Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof |
US6964950B2 (en) | 2001-07-25 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of C-reactive protein expression |
US7425545B2 (en) * | 2001-07-25 | 2008-09-16 | Isis Pharmaceuticals, Inc. | Modulation of C-reactive protein expression |
US7176303B2 (en) * | 2003-11-06 | 2007-02-13 | Isis Pharmaceuticals, Inc. | Modulation of STAT5 expression |
US7199107B2 (en) * | 2002-05-23 | 2007-04-03 | Isis Pharmaceuticals, Inc. | Antisense modulation of kinesin-like 1 expression |
AU2003241871A1 (en) * | 2002-05-28 | 2003-12-12 | National Institute Of Advanced Industrial Science And Technology | Chemical sensor system |
JP2004016054A (ja) * | 2002-06-13 | 2004-01-22 | Takara Bio Inc | ポリペプチドの細胞表面局在化方法 |
WO2004029577A2 (en) * | 2002-09-26 | 2004-04-08 | Fmc Corporation | Hemipteran myosin light chain kinase |
US20060009410A1 (en) * | 2002-11-13 | 2006-01-12 | Crooke Rosanne M | Effects of apolipoprotein B inhibition on gene expression profiles in animals |
WO2005071080A2 (en) * | 2004-01-20 | 2005-08-04 | Isis Pharmaceuticals, Inc. | Modulation of glucocorticoid receptor expression |
EP1778877B1 (de) * | 2004-07-28 | 2009-10-21 | Canon U.S. Life Sciences, Inc. | Verfahren zur überwachung genomischer dna von organismen |
HUE026284T2 (en) * | 2004-08-10 | 2016-06-28 | Genzyme Corp | Oligonucleotides for use in modulating lipoprotein and cholesterol levels in humans |
WO2006089192A2 (en) * | 2005-02-18 | 2006-08-24 | Canon U.S. Life Sciences, Inc. | Devices and methods for identifying genomic dna of organisms |
US20070185044A1 (en) * | 2005-03-08 | 2007-08-09 | Dobie Kenneth W | Modulation of ace2 expression |
US8658608B2 (en) * | 2005-11-23 | 2014-02-25 | Yale University | Modified triple-helix forming oligonucleotides for targeted mutagenesis |
US8084734B2 (en) * | 2006-05-26 | 2011-12-27 | The George Washington University | Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays |
WO2009061852A2 (en) * | 2007-11-09 | 2009-05-14 | Isis Pharmaceuticals, Inc. | Modulation of factor 9 expression |
US8110796B2 (en) | 2009-01-17 | 2012-02-07 | The George Washington University | Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays |
WO2010093906A2 (en) * | 2009-02-12 | 2010-08-19 | Curna, Inc. | Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
US9490113B2 (en) * | 2009-04-07 | 2016-11-08 | The George Washington University | Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry |
ES2585360T3 (es) * | 2009-08-05 | 2016-10-05 | Curna, Inc. | Tratamiento de enfermedades relacionadas con un gen de la insulina (INS) por inhibición de la transcripción antisentido natural en un gen de la insulina (INS) |
MX342405B (es) | 2010-06-03 | 2016-09-28 | Pharmacyclics Inc | El uso de inhibidores de la tirosina quinasa de bruton (btk). |
WO2011163499A2 (en) * | 2010-06-23 | 2011-12-29 | Opko Curna, Llc | Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
KR20180105730A (ko) | 2010-07-19 | 2018-09-28 | 아이오니스 파마수티컬즈, 인코포레이티드 | 근육긴장성 이영양증-단백질 키나제(dmpk) 발현의 조절 방법 |
WO2012033462A1 (en) * | 2010-09-06 | 2012-03-15 | Temasek Life Sciences Laboratory Limited | Molecular interaction between xa10 and avrxa10 |
WO2012038827A2 (en) * | 2010-09-20 | 2012-03-29 | Prognomix Inc. | Genes linking several complications of type-2 diabetes (t2d) |
US8648053B2 (en) * | 2010-10-20 | 2014-02-11 | Rosalind Franklin University Of Medicine And Science | Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome |
AU2013206424B2 (en) * | 2010-11-24 | 2015-09-17 | E. I. Du Pont De Nemours And Company | Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof |
US9157125B2 (en) | 2011-02-02 | 2015-10-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | GRIN2A mutations and use thereof for the diagnosis of melanoma |
MY185926A (en) * | 2011-07-15 | 2021-06-14 | Acgt Sdn Bhd | Ssr markers for plants and uses thereof |
US10526642B2 (en) | 2011-08-25 | 2020-01-07 | Commonwealth Scientific And Industrial Research Organisation | DNA methylation in colorectal and breast cancer diagnostic methods |
WO2013071022A1 (en) * | 2011-11-10 | 2013-05-16 | Shire Human Genetic Therapies, Inc. | Antisense oligonucleotide modulators of serotonin receptor 2c and uses thereof |
JP6492003B2 (ja) | 2012-03-30 | 2019-03-27 | ワシントン・ユニバーシティWashington University | 発作を減少させるためおよび神経変性症候群を改質するためにタウ発現を調節する方法 |
JP2015518710A (ja) | 2012-05-16 | 2015-07-06 | ラナ セラピューティクス インコーポレイテッド | ヘモグロビン遺伝子ファミリー発現を調節するための組成物及び方法 |
KR20160074368A (ko) | 2012-05-16 | 2016-06-28 | 라나 테라퓨틱스, 인크. | Utrn 발현을 조절하기 위한 조성물 및 방법 |
EA201492123A1 (ru) | 2012-05-16 | 2015-10-30 | Рана Терапьютикс, Инк. | Композиции и способы для модулирования экспрессии семейства генов smn |
WO2013173608A1 (en) | 2012-05-16 | 2013-11-21 | Rana Therapeutics, Inc. | Compositions and methods for modulating mecp2 expression |
CA2873766A1 (en) | 2012-05-16 | 2013-11-21 | Rana Therapeutics Inc. | Compositions and methods for modulating atp2a2 expression |
US10837014B2 (en) | 2012-05-16 | 2020-11-17 | Translate Bio Ma, Inc. | Compositions and methods for modulating SMN gene family expression |
WO2014018375A1 (en) * | 2012-07-23 | 2014-01-30 | Xenon Pharmaceuticals Inc. | Cyp8b1 and uses thereof in therapeutic and diagnostic methods |
AU2013293087B2 (en) | 2012-07-24 | 2017-08-31 | Pharmacyclics Llc | Mutations associated with resistance to inhibitors of Bruton's tyrosine kinase (BTK) |
US9175291B2 (en) | 2012-10-11 | 2015-11-03 | Isis Pharmaceuticals Inc. | Modulation of androgen receptor expression |
WO2014134255A2 (en) * | 2013-02-28 | 2014-09-04 | Novartis Ag | Organic compositions to treat epas1-related diseases |
EP2971103A1 (de) * | 2013-03-14 | 2016-01-20 | Cepheid | Verfahren für den nachweis von lungenkrebs |
NZ631098A (en) | 2013-03-15 | 2016-09-30 | Intrinsic Lifesciences Llc | Anti-hepcidin antibodies and uses thereof |
TWI657819B (zh) | 2013-07-19 | 2019-05-01 | 美商Ionis製藥公司 | 用於調節τ蛋白表現之組合物 |
TW201536329A (zh) | 2013-08-09 | 2015-10-01 | Isis Pharmaceuticals Inc | 用於調節失養性肌強直蛋白質激酶(dmpk)表現之化合物及方法 |
US11162096B2 (en) | 2013-10-14 | 2021-11-02 | Ionis Pharmaceuticals, Inc | Methods for modulating expression of C9ORF72 antisense transcript |
US20160186261A1 (en) * | 2013-11-04 | 2016-06-30 | Jose U. Scher | Prevotella copri and enhanced susceptibility to arthritis |
WO2015143400A1 (en) * | 2014-03-20 | 2015-09-24 | Pharmacyclics, Inc. | Phospholipase c gamma 2 and resistance associated mutations |
EP3757214B1 (de) | 2014-04-01 | 2022-06-15 | Biogen MA Inc. | Zusammensetzungen zur modulierung der sod-1-expression |
JP6680760B2 (ja) * | 2014-07-31 | 2020-04-15 | アカデミア シニカAcademia Sinica | アンタゴニストic pd−1アプタマー及びその癌治療関連用途への応用 |
WO2016034611A1 (en) * | 2014-09-02 | 2016-03-10 | Max-Delbrück-Centrum für Molekulare Medizin | Antisense oligonucleotides targeting 3'utr region of a20 |
WO2016049036A1 (en) | 2014-09-22 | 2016-03-31 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
EP3416976A2 (de) | 2016-02-16 | 2018-12-26 | Yale University | Zusammensetzungen zur verbesserung von gezielter geneditierung und verfahren zur verwendung davon |
JOP20190065A1 (ar) | 2016-09-29 | 2019-03-28 | Ionis Pharmaceuticals Inc | مركبات وطرق لتقليل التعبير عن tau |
GB201711782D0 (en) * | 2017-07-21 | 2017-09-06 | Ucl Business Plc | Diagnostic and Prognostic methods |
TW202000199A (zh) | 2018-03-02 | 2020-01-01 | 美商Ionis製藥公司 | Irf4 表現之調節劑 |
US11365416B2 (en) | 2018-04-11 | 2022-06-21 | Ionis Pharmaceuticals, Inc. | Modulators of EZH2 expression |
BR112020021400A2 (pt) * | 2018-04-18 | 2021-01-19 | Pioneer Hi-Bred International, Inc. | Genes, construtos e evento dp-202216-6 de milho |
EP3927827A4 (de) * | 2019-02-22 | 2023-04-26 | Ionis Pharmaceuticals, Inc. | Verbindungen und verfahren zur verminderung der atxn3-expression |
CN110343764B (zh) * | 2019-07-22 | 2020-05-26 | 武汉艾米森生命科技有限公司 | 检测结直肠癌相关基因甲基化的检测试剂的应用和试剂盒 |
BR112022014671A2 (pt) * | 2020-01-27 | 2023-02-28 | Pioneer Hi Bred Int | Evento de milho dp-056113-9 e métodos de uso do mesmo |
CA3227115A1 (en) * | 2021-07-21 | 2023-01-26 | Wen-Hsuan Chang | Unc13a antisense oligonucleotides |
WO2023034870A2 (en) | 2021-09-01 | 2023-03-09 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing dmpk expression |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011995A1 (en) * | 1993-10-26 | 1995-05-04 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
WO1999028498A2 (de) * | 1997-11-27 | 1999-06-10 | Epigenomics Gmbh | Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
-
2001
- 2001-04-06 EP EP01923891A patent/EP1268856A2/de not_active Withdrawn
- 2001-04-06 AU AU2001250572A patent/AU2001250572A1/en not_active Abandoned
- 2001-04-06 US US10/257,017 patent/US20040241651A1/en not_active Abandoned
- 2001-04-06 WO PCT/IB2001/000713 patent/WO2001077384A2/de not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011995A1 (en) * | 1993-10-26 | 1995-05-04 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
WO1999028498A2 (de) * | 1997-11-27 | 1999-06-10 | Epigenomics Gmbh | Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke |
Non-Patent Citations (4)
Title |
---|
HERMAN J G ET AL: "METHYLATION-SPECIFIC PCR: A NOVEL PCR ASSAY FOR METHYLATION STATUS OF CPG ISLANDS" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, Bd. 93, 1. September 1996 (1996-09-01), Seiten 9821-9826, XP002910406 ISSN: 0027-8424 * |
NIEMEYER C M ET AL: "DNA MICROARRAYS**" ANGEWANDTE CHEMIE, VCH VERLAGSGESELLSCHAFT, WEINHEIM, DE, Bd. 38, Nr. 19, 1999, Seiten 3039-3043, XP000961724 ISSN: 0044-8249 * |
REIN ET AL: "Identifying 5-methylcytosine and related modifications in DNA genomes" NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, Bd. 26, Nr. 10, 1998, Seiten 2255-2264, XP002143106 ISSN: 0305-1048 * |
WANG D G ET AL: "Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, Bd. 280, 1998, Seiten 1077-1082, XP002089398 ISSN: 0036-8075 * |
Cited By (188)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7888324B2 (en) | 2001-08-01 | 2011-02-15 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
US7407943B2 (en) | 2001-08-01 | 2008-08-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein B expression |
US8735364B2 (en) | 2001-08-01 | 2014-05-27 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
WO2003060160A2 (en) * | 2002-01-18 | 2003-07-24 | Genomar Asa | Verification of fish origin based on nucleic acid pattern recognition |
WO2003060160A3 (en) * | 2002-01-18 | 2003-12-24 | Genomar Asa | Verification of fish origin based on nucleic acid pattern recognition |
WO2003064700A2 (en) * | 2002-01-30 | 2003-08-07 | Epigenomics Ag | Identification of cell differentiation states based on methylation patterns |
WO2003064700A3 (en) * | 2002-01-30 | 2003-11-13 | Epigenomics Ag | Identification of cell differentiation states based on methylation patterns |
EP1352974A1 (de) * | 2002-04-02 | 2003-10-15 | Tosoh Corporation | Oligonukleotide zum Nachweis des untypischen Mycobacteriums Mycobacterium avium und Nachweisverfahren |
AU2008255238B2 (en) * | 2002-05-06 | 2012-06-28 | Genesis Research And Development Corporation Limited | Compositions isolated from forage grasses and methods for their use |
EP1365032B1 (de) * | 2002-05-21 | 2008-11-19 | MTM Laboratories AG | Marker für Lungentumore |
WO2004006941A1 (en) * | 2002-07-17 | 2004-01-22 | Index Pharmaceuticals Ab | Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders |
WO2004029302A1 (en) * | 2002-09-26 | 2004-04-08 | Stichting Researchfonds Pathologie | Method for detecting and typing of cutaneous hpv and primers and probes for use therein |
EP1403384A1 (de) * | 2002-09-26 | 2004-03-31 | Stichting Researchfonds Pathologie | Verfahren zum Nachweis und zur Karakterisierung von kutanem HPV und Primer und Sonden dafür |
USRE44760E1 (en) | 2002-11-13 | 2014-02-11 | Genzyme Corporation | Antisense modulation of apolipoprotein B-expression |
US7803930B2 (en) * | 2002-11-13 | 2010-09-28 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein B-expression |
US7511131B2 (en) * | 2002-11-13 | 2009-03-31 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
US20110190370A1 (en) * | 2002-11-23 | 2011-08-04 | Isis Pharmaceuticals, Inc. | Modulation of hif1(alpha) and hif2(alpha) expression |
US8513400B2 (en) * | 2002-11-23 | 2013-08-20 | Isis Pharmaceuticals, Inc. | Modulation of HIF1α and HIF2α expression |
US9982311B2 (en) | 2002-12-31 | 2018-05-29 | Branhaven LLC | Compositions, methods, and systems for inferring bovine breed |
US11053547B2 (en) | 2002-12-31 | 2021-07-06 | Branhaven LLC | Methods and systems for inferring bovine traits |
US8669056B2 (en) | 2002-12-31 | 2014-03-11 | Cargill Incorporated | Compositions, methods, and systems for inferring bovine breed |
US10190167B2 (en) | 2002-12-31 | 2019-01-29 | Branhaven LLC | Methods and systems for inferring bovine traits |
US9963749B2 (en) | 2003-01-31 | 2018-05-08 | Monsanto Technology Llc | Glyphosate tolerant alfalfa events and methods for detection thereof |
US7566817B2 (en) | 2003-01-31 | 2009-07-28 | Monsanto Technology Llc | Glyphosate tolerant alfalfa events and methods for detection |
US9068196B2 (en) | 2003-01-31 | 2015-06-30 | Monsanto Technology Llc | Glyphosate tolerant alfalfa events and methods for detection thereof |
US8124848B2 (en) | 2003-01-31 | 2012-02-28 | Monsanto Technology Llc | Glyphosate tolerant alfalfa events and methods for detection thereof |
WO2004070020A3 (en) * | 2003-01-31 | 2004-11-11 | Monsanto Technology Llc | Glyphosate tolerant alfalfa events and methods for detection thereof |
EP2270189A1 (de) * | 2003-01-31 | 2011-01-05 | Monsanto Technology LLC | Glyphosat-tolerante Luzernepflanzen und Verfahren zu deren Detektion |
US7846906B2 (en) | 2003-02-28 | 2010-12-07 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US8623836B2 (en) | 2003-02-28 | 2014-01-07 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US8637484B2 (en) | 2003-02-28 | 2014-01-28 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US8299039B2 (en) | 2003-02-28 | 2012-10-30 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US9988635B2 (en) | 2003-02-28 | 2018-06-05 | Antisense Therapeutics Limited | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US7803781B2 (en) * | 2003-02-28 | 2010-09-28 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US9371530B2 (en) | 2003-02-28 | 2016-06-21 | Antisense Therapeutics Ltd. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
US7722879B2 (en) * | 2003-07-10 | 2010-05-25 | Intervet International B.V. | Babesia vaccines |
US7910563B2 (en) * | 2003-08-12 | 2011-03-22 | Antisense Pharma Gmbh | Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA |
WO2005033284A3 (en) * | 2003-10-01 | 2005-07-07 | Univ California | Compositions and methods for gene expression |
US8026414B2 (en) * | 2003-10-27 | 2011-09-27 | Fnp Corp., Ltd. | Molecular marker associated with CMV resistance and use thereof |
EP1689889B1 (de) * | 2003-12-01 | 2017-08-30 | Epigenomics AG | Verfahren und nukleinsäuren zur analyse der mit der entwicklung von prostatazellproliferationsstörungen assoziierten genexpression |
EP1689889A2 (de) * | 2003-12-01 | 2006-08-16 | Epigenomics AG | Verfahren und nukleinsäuren zur analyse der mit der entwicklung von prostatazellproliferationsstörungen assoziierten genexpression |
US7297785B2 (en) * | 2004-03-24 | 2007-11-20 | United States Of America As Represented By The Secretary Of The Army | Unique chromosomal sequence of Bacillus anthracis and methods of making and using thereof including real-time PCR assays |
AU2005229157B2 (en) * | 2004-03-31 | 2011-07-21 | Commonwealth Scientific And Industrial Research Organisation | Genes involved in plant fibre development |
US9340797B2 (en) | 2004-04-09 | 2016-05-17 | Monsanto Technology Llc | Compositions and methods for control of insect infestations in plants |
US11685930B2 (en) | 2004-04-09 | 2023-06-27 | Monsanto Technology, Llc | Compositions and methods for control of insect infestations in plants |
US9238822B2 (en) | 2004-04-09 | 2016-01-19 | Monsanto Technology Llc | Compositions and methods for control of insect infestations in plants |
US11492638B2 (en) | 2004-04-09 | 2022-11-08 | Monsanto Technology, Llc | Compositions and methods for control of insect infestations in plants |
US8946510B2 (en) | 2004-04-09 | 2015-02-03 | Monsanto Technology Llc | Compositions and methods for control of insect infestations in plants |
US10787680B2 (en) | 2004-04-09 | 2020-09-29 | Monsanto Technology Llc | Compositions and methods for control of insect infestations in plants |
US10167484B2 (en) | 2004-04-09 | 2019-01-01 | Monsanto Technology Llc | Compositions and methods for control of insect infestations in plants |
US8383807B2 (en) | 2004-04-13 | 2013-02-26 | The Rockefeller University | MicroRNA and methods for inhibiting same |
US8697859B2 (en) | 2004-04-13 | 2014-04-15 | The Rockefeller University | MicroRNA and methods for inhibiting same |
US9200290B2 (en) | 2004-04-13 | 2015-12-01 | The Rockefeller University | MicroRNA and methods for inhibiting same |
US8088914B2 (en) | 2004-04-13 | 2012-01-03 | The Rockefeller University | MicroRNA and methods for inhibiting same |
US9382539B2 (en) | 2004-04-13 | 2016-07-05 | The Rockefeller University | MicroRNA and methods for inhibiting same |
US8916694B2 (en) | 2004-05-05 | 2014-12-23 | Genzyme Corporation | SNPs of apolipoprotein B and modulation of their expression |
WO2005116658A3 (en) * | 2004-05-24 | 2006-05-26 | Anamar Medical Ab | Method for determining a tissue degradation process by detection of comp neoepitopes |
US9675757B2 (en) | 2004-05-28 | 2017-06-13 | Cilag Gmbh International | Injection device |
US8313464B2 (en) | 2004-05-28 | 2012-11-20 | Cilag Gmbh International | Injection device |
US9675758B2 (en) | 2004-05-28 | 2017-06-13 | Cilag Gmbh International | Injection device |
US8313465B2 (en) | 2004-05-28 | 2012-11-20 | Cilag Gmbh International | Injection device |
US8313463B2 (en) | 2004-05-28 | 2012-11-20 | Cilag Gmbh International | Injection device |
US8277414B2 (en) | 2004-05-28 | 2012-10-02 | Cilag Gmbh International | Injection device |
US9895493B2 (en) | 2004-05-28 | 2018-02-20 | Cilag Gmbh International | Injection device |
US7807647B2 (en) * | 2004-06-01 | 2010-10-05 | Pronai Therapeutics, Inc. | Methods and compositions for cancer therapy |
US7498315B2 (en) * | 2004-06-01 | 2009-03-03 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
US8815599B2 (en) | 2004-06-01 | 2014-08-26 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
US7524827B2 (en) * | 2004-06-01 | 2009-04-28 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
US9393258B2 (en) | 2004-06-01 | 2016-07-19 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
US8409856B2 (en) | 2004-09-13 | 2013-04-02 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to gemin genes |
US7759479B1 (en) * | 2004-09-13 | 2010-07-20 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to Gemin Genes |
US7833710B2 (en) | 2005-02-14 | 2010-11-16 | Samsung Electronics Co., Ltd. | Polynucleotide associated with breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing breast cancer using the same |
US9649441B2 (en) | 2005-04-06 | 2017-05-16 | Cilag Gmbh International | Injection device (bayonet cap removal) |
US9731080B2 (en) | 2005-04-06 | 2017-08-15 | Cilag Gmbh International | Injection device |
US8968236B2 (en) | 2005-04-06 | 2015-03-03 | Cilag Gmbh International | Injection device |
US8513491B2 (en) | 2005-07-06 | 2013-08-20 | Nestec S.A. | Dehydrin genes and promoters from coffee |
WO2007005980A2 (en) * | 2005-07-06 | 2007-01-11 | Cornell Research Foundation | Dehydrin genes and promoters from coffee |
WO2007005980A3 (en) * | 2005-07-06 | 2007-08-16 | Cornell Res Foundation Inc | Dehydrin genes and promoters from coffee |
US9358346B2 (en) | 2005-08-30 | 2016-06-07 | Cilag Gmbh International | Needle assembly for a prefilled syringe system |
EP2431473A1 (de) * | 2005-09-16 | 2012-03-21 | Monsanto Technology LLC | Verfahren zur genetischen Kontrolle von Insektenplagen bei Pflanzen und Zusammensetzungen dafür |
US11939589B2 (en) | 2005-09-16 | 2024-03-26 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
EP2439279A1 (de) * | 2005-09-16 | 2012-04-11 | Monsanto Technology LLC | Verfahren zur genetischen Kontrolle von Insektenplagen bei Pflanzen und Zusammensetzungen dafür |
US9695439B2 (en) | 2005-09-16 | 2017-07-04 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
US10538783B2 (en) | 2005-09-16 | 2020-01-21 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
US11312975B2 (en) | 2005-09-16 | 2022-04-26 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
EP2439278A1 (de) * | 2005-09-16 | 2012-04-11 | Monsanto Technology LLC | Verfahren zur genetischen Kontrolle von Insektenplagen bei Pflanzen und Zusammensetzungen dafür |
AU2014277739B2 (en) * | 2005-09-16 | 2017-02-02 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
US8759611B2 (en) | 2005-09-16 | 2014-06-24 | Monsanto Technology Llc | Methods for genetic control of insect infestation in plants and compositions thereof |
US9770558B2 (en) | 2005-09-27 | 2017-09-26 | Cilag Gmbh International | Auto-injection device with needle protecting cap having outer and inner sleeves |
US8367628B2 (en) | 2005-12-01 | 2013-02-05 | Pronai Therapeutics, Inc. | Amphoteric liposome formulation |
US7632824B2 (en) * | 2006-03-16 | 2009-12-15 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of Mcl-1 expression |
US9045754B2 (en) | 2006-05-05 | 2015-06-02 | Isis Pharmaceuticals, Inc. | Short antisense compounds with gapmer configuration |
US9072833B2 (en) | 2006-06-01 | 2015-07-07 | Cilag Gmbh International | Injection device |
US9757520B2 (en) | 2006-06-01 | 2017-09-12 | Cilag Gmbh International | Injection device |
US9028451B2 (en) | 2006-06-01 | 2015-05-12 | Cilag Gmbh International | Injection device |
US7745595B2 (en) * | 2006-08-10 | 2010-06-29 | Medical Diagnostic Laboratories, Llc | Compositions and methods for detecting Atopobium vaginae |
AU2014200037B2 (en) * | 2006-10-10 | 2016-06-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
WO2008046911A2 (en) * | 2006-10-20 | 2008-04-24 | Exiqon A/S | Novel human micrornas associated with cancer |
US8188255B2 (en) | 2006-10-20 | 2012-05-29 | Exiqon A/S | Human microRNAs associated with cancer |
WO2008046911A3 (en) * | 2006-10-20 | 2008-07-03 | Exiqon As | Novel human micrornas associated with cancer |
US9347061B2 (en) | 2007-03-24 | 2016-05-24 | Genzyme Corporation | Administering antisense oligonucleotides complementary to human apolipoprotein B |
EP2261366A1 (de) * | 2007-11-23 | 2010-12-15 | Epigenomics AG | Verfahren und Nukleinsäuren zur Analyse der Genexpression, die mit der Entwicklung von mit der prostatischen Zellproliferation assozierten Krankheiten einhergeht |
EP2390371A1 (de) * | 2007-11-30 | 2011-11-30 | Genomictree, Inc. | Diagnosekit und Chip für Blasenkrebs mit blasenkrebsspezifischem Methylierungsmarkergen |
EP2246422A4 (de) * | 2008-01-24 | 2012-07-25 | Nat Inst Of Advanced Ind Scien | Polynukleotid oder analogon davon und verfahren zur genexpressionsregulierung mit dem polynukleotid oder dem analogon davon |
EP2246422A1 (de) * | 2008-01-24 | 2010-11-03 | National Institute of Advanced Industrial Science And Technology | Polynukleotid oder analogon davon und verfahren zur genexpressionsregulierung mit dem polynukleotid oder dem analogon davon |
CN101649354A (zh) * | 2008-04-21 | 2010-02-17 | 法国国家基因中心 | 核糖核苷酸标记核酸检测 |
US10150990B2 (en) | 2008-04-21 | 2018-12-11 | Roche Molecular Systems, Inc. | Ribonucleotide tag nucleic acid detection |
US8845594B2 (en) | 2008-06-19 | 2014-09-30 | Cilag Gmbh International | Auto-injector with filling means |
US8939958B2 (en) | 2008-06-19 | 2015-01-27 | Cilag Gmbh International | Fluid transfer assembly for a syringe |
US9682194B2 (en) | 2008-06-19 | 2017-06-20 | Cilag Gmbh International | Re-useable auto-injector with filling means |
US9028453B2 (en) | 2008-06-19 | 2015-05-12 | Cilag Gmbh International | Reusable auto-injector |
US8834419B2 (en) | 2008-06-19 | 2014-09-16 | Cilag Gmbh International | Reusable auto-injector |
US9109250B2 (en) | 2009-01-30 | 2015-08-18 | Vanessa Hill | Production of closed linear DNA |
US11384388B2 (en) | 2009-01-30 | 2022-07-12 | Touchlight IP Limited | DNA vaccines |
US10519448B2 (en) * | 2009-02-12 | 2019-12-31 | Curna, Inc. | Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF |
US20160138023A1 (en) * | 2009-02-12 | 2016-05-19 | Curna, Inc. | Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
US9107933B2 (en) | 2009-03-16 | 2015-08-18 | Isis Pharmaceuticals, Inc. | Compositions and methods of targeting apolipoprotein B for the reduction of apolipoprotein C-III |
WO2011061184A1 (en) * | 2009-11-17 | 2011-05-26 | Centre National De La Recherche Scientifique (C.N.R.S) | Methods for diagnosing skin diseases |
EP2322656A1 (de) * | 2009-11-17 | 2011-05-18 | Centre National de la Recherche Scientifique (C.N.R.S) | Verfahren zur Diagnose von Hautkrankheiten |
US9994918B2 (en) * | 2010-05-25 | 2018-06-12 | National University Of Ireland, Galway | Diagnostic method |
CN103080337B (zh) * | 2010-08-04 | 2016-08-17 | 触光基因学有限公司 | 利用回文序列生产闭合线性dna |
WO2012017210A1 (en) * | 2010-08-04 | 2012-02-09 | Touchlight Genetics Limited | Production of closed linear dna using a palindromic sequence |
US20130216562A1 (en) * | 2010-08-04 | 2013-08-22 | Neil Porter | Production of closed linear dna using a palindromic sequence |
CN103080337A (zh) * | 2010-08-04 | 2013-05-01 | 触光基因学有限公司 | 利用回文序列生产闭合线性dna |
US9499847B2 (en) | 2010-08-04 | 2016-11-22 | Touchlight IP Limited | Production of closed linear DNA using a palindromic sequence |
US11685956B2 (en) | 2010-11-15 | 2023-06-27 | Exact Sciences Corporation | Methylation assay |
EP2640858A2 (de) * | 2010-11-15 | 2013-09-25 | Exact Sciences Corporation | Methylierungsassay |
US8916344B2 (en) | 2010-11-15 | 2014-12-23 | Exact Sciences Corporation | Methylation assay |
EP2640858A4 (de) * | 2010-11-15 | 2014-04-16 | Exact Sciences Corp | Methylierungsassay |
US20180073022A1 (en) * | 2010-11-17 | 2018-03-15 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
US10815480B2 (en) * | 2010-11-17 | 2020-10-27 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
EP2663658B1 (de) * | 2011-01-12 | 2017-10-25 | Abbott Molecular Inc. | Materialen und verfahren zum nachweis von cytomegalovirus (cmv) |
US9404114B2 (en) | 2011-09-20 | 2016-08-02 | Ionis Pharmaceuticals, Inc. | Antisense modulation of GCGR expression |
WO2013043817A1 (en) | 2011-09-20 | 2013-03-28 | Isis Phamaceuticals, Inc. | Antisense modulation of gcgr expression |
EP3401401A1 (de) * | 2011-09-20 | 2018-11-14 | Ionis Pharmaceuticals, Inc. | Antisense-modulation der gcgr-expression |
EP2758533A4 (de) * | 2011-09-20 | 2015-08-05 | Isis Pharmaceuticals Inc | Antisense-modulation der gcgr-expression |
US10689635B2 (en) | 2011-10-17 | 2020-06-23 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US11174472B2 (en) | 2011-10-17 | 2021-11-16 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2013095119A1 (en) * | 2011-12-14 | 2013-06-27 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws | Identification of poliovirus strains |
JPWO2014034952A1 (ja) * | 2012-09-03 | 2016-08-08 | 国立大学法人九州大学 | がんに対する免疫療法の有効性の予測方法 |
US10253366B2 (en) | 2013-03-08 | 2019-04-09 | Progenika Biopharma, S.A. | Discrimination of blood type variants |
WO2014135331A1 (en) * | 2013-03-08 | 2014-09-12 | Progenika Biopharma S.A. | Discrimination of blood type variants |
US9359643B2 (en) | 2013-03-08 | 2016-06-07 | Progenika Biopharma S.A. | Discrimination of blood type variants |
US20220243200A1 (en) * | 2013-03-14 | 2022-08-04 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating tau expression |
US10709849B2 (en) | 2013-06-11 | 2020-07-14 | Cilag Gmbh International | Guide for an injection device |
US11173255B2 (en) | 2013-06-11 | 2021-11-16 | Cilag Gmbh International | Injection device |
US11123492B2 (en) | 2013-06-11 | 2021-09-21 | Cilag Gmbh International | Injection device |
US10799646B2 (en) | 2013-06-11 | 2020-10-13 | Cilag Gmbh International | Injection device |
US20160160216A1 (en) * | 2013-06-14 | 2016-06-09 | Deutsches Krebsforschungszentrum | Ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention |
US10457938B2 (en) * | 2013-06-14 | 2019-10-29 | Deutsches Krebsforschungszentrum | TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention |
RU2700244C2 (ru) * | 2013-07-02 | 2019-09-13 | Ионис Фармасьютикалз, Инк. | Модуляторы рецептора гормона роста |
EP3017044A4 (de) * | 2013-07-02 | 2017-06-14 | Ionis Pharmaceuticals, Inc. | Modulatoren des wachstumshormonrezeptors |
EP3730614A3 (de) * | 2013-07-02 | 2020-12-30 | Ionis Pharmaceuticals, Inc. | Modulatoren des wachstumshormonrezeptors |
AU2014284398B2 (en) * | 2013-07-02 | 2019-10-31 | Ionis Pharmaceuticals, Inc. | Modulators of growth hormone receptor |
WO2015028807A1 (en) * | 2013-08-30 | 2015-03-05 | The Secretary Of State For Health | Assay for the detection of infection-causing e. coli strains |
EP3058098A4 (de) * | 2013-10-18 | 2017-03-22 | Institut de Cardiologie de Montréal | Genotypisierungstests und verfahren zur beurteilung von plasmakreatin-kinasepegeln |
US9994855B2 (en) | 2014-05-01 | 2018-06-12 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating growth hormone receptor expression |
US10793862B2 (en) | 2014-05-01 | 2020-10-06 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating growth hormone receptor expression |
US11312964B2 (en) | 2014-05-01 | 2022-04-26 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating growth hormone receptor expression |
US20170356052A1 (en) * | 2014-11-18 | 2017-12-14 | Blueprint Medicines Corporation | Prkacb fusions |
US10604769B2 (en) | 2015-11-02 | 2020-03-31 | Monsanto Technology Llc | Cotton transgenic event MON 88702 and methods for detection and uses thereof |
US11286499B2 (en) | 2015-11-02 | 2022-03-29 | Monsanto Technology Llc | Cotton transgenic event MON 88702 and methods for detection and uses thereof |
WO2017079266A1 (en) * | 2015-11-02 | 2017-05-11 | Monsanto Technology Llc | Cotton transgenic event mon 88702 and methods for detection and uses thereof |
US11414704B2 (en) | 2016-06-08 | 2022-08-16 | University Of Iowa Research Foundation | Compositions and methods for detecting predisposition to cardiovascular disease |
EP3907300A1 (de) * | 2016-06-08 | 2021-11-10 | University Of Iowa Research Foundation | Zusammensetzungen zum nachweis der prädisposition für kardiovaskuläre erkrankungen |
WO2017214397A1 (en) * | 2016-06-08 | 2017-12-14 | University Of Iowa Research Foundation | Compositions and methods for detecting predisposition to cardiovascular disease |
AU2017277666B2 (en) * | 2016-06-08 | 2023-07-27 | University Of Iowa Research Foundation | Compositions and methods for detecting predisposition to cardiovascular disease |
US11666595B2 (en) | 2016-10-07 | 2023-06-06 | Secarna Pharmaceuticals Gmbh & Co. Kg | Antisense oligonucleotides for inhibition of PD-L1 expression and treating cancer |
NO20170739A1 (en) * | 2017-05-04 | 2018-11-05 | Patogen As | Novel virus in Fish and Method for detection |
NO344051B1 (en) * | 2017-05-04 | 2019-08-26 | Patogen As | Novel virus in Fish and Method for detection |
CN110997914A (zh) * | 2017-05-11 | 2020-04-10 | 纽约州立大学研究基金会 | 用于向细胞外囊泡装载化学和生物试剂/分子的组合物和方法 |
US11814626B2 (en) | 2017-05-11 | 2023-11-14 | The Research Foundation For The State University Of New York | Compositions and methods for loading extracellular vesicles with chemical and biological agents/molecules |
WO2018209182A3 (en) * | 2017-05-11 | 2018-12-20 | The Research Foundation For The State University Of New York | Compositions and methods for loading extracellular vesicles with chemical and biological agents/molecules |
WO2018220385A1 (en) * | 2017-05-31 | 2018-12-06 | Blue Genomics Chile Spa. | Genetic identification of piscirickettsia salmonis resistant salmonids |
US11230712B2 (en) | 2017-11-09 | 2022-01-25 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing SNCA expression |
US11359197B2 (en) | 2018-01-12 | 2022-06-14 | Bristol-Myers Squibb Company | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
US11447775B2 (en) | 2018-01-12 | 2022-09-20 | Bristol-Myers Squibb Company | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
RU2802418C2 (ru) * | 2018-05-18 | 2023-08-28 | Олипасс Корпорейшн | Антисмысловые олигонуклеотиды матриксной металлопротеиназы-1 |
EP3794124A4 (de) * | 2018-05-18 | 2022-08-10 | Olipass Corporation | Matrix-metalloproteinase-1-antisense-oligonukleotide |
WO2019233921A1 (en) * | 2018-06-05 | 2019-12-12 | F. Hoffmann-La Roche Ag | Oligonucleotides for modulating atxn2 expression |
US11066669B2 (en) | 2018-06-05 | 2021-07-20 | Hoffmann-La Roche Inc. | Oligonucleotides for modulating ATXN2 expression |
US11547718B2 (en) | 2018-11-14 | 2023-01-10 | Ionis Pharmaceuticals, Inc. | Modulators of FOXP3 expression |
EP3693465A1 (de) * | 2019-02-05 | 2020-08-12 | Pharmaq AS | Neuartiger fisch-coronavirus |
US11286485B2 (en) | 2019-04-04 | 2022-03-29 | Hoffmann-La Roche Inc. | Oligonucleotides for modulating ATXN2 expression |
JP7386507B2 (ja) | 2019-08-02 | 2023-11-27 | 国立大学法人信州大学 | 筋分化促進剤および筋分化促進方法および筋分化促進オリゴdna |
WO2021165828A1 (en) * | 2020-02-17 | 2021-08-26 | 3M Innovative Properties Company | Loop-mediated isothermal amplification primers for vibrio parahaemolyticus detection and uses thereof |
WO2021191369A1 (en) * | 2020-03-27 | 2021-09-30 | Precision For Medicine Gmbh | Cbx6 as epigenetic marker for the identification of immune cells, in particular memory b cells |
WO2022016222A1 (en) * | 2020-07-22 | 2022-01-27 | The Florey Institute Of Neuroscience And Mental Health | Compositions and methods for treating disorders associated with loss-of-function mutations in scn2a |
Also Published As
Publication number | Publication date |
---|---|
EP1268856A2 (de) | 2003-01-02 |
WO2001077384A3 (de) | 2002-07-25 |
AU2001250572A1 (en) | 2001-10-23 |
US20040241651A1 (en) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001077384A2 (de) | DETEKTION VON SNPs UND CYTOSIN-METHYLIERUNGEN | |
EP1423528B1 (de) | Verfahren zur bestimmung des methylierungsgrades von bestimmten cytosinen in genomischer dna im sequenzkontext 5'-cpg-3' | |
DE10010280B4 (de) | Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben | |
DE10056802B4 (de) | Verfahren zur Detektion von Methylierungszuständen zur toxikologischen Diagnostik | |
DE10151055B4 (de) | Verfahren zum Nachweis von Cytosin-Methylierung in CpG Inseln | |
WO2002018631A2 (de) | Diagnose von bestehenden erkrankungen oder der prädisposition für bestimmte erkrankungen | |
DE10154317B4 (de) | Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben | |
DE10132212B4 (de) | Verfahren zum Nachweis von Cytosin-Methylierung durch vergleichende Analyse der Einzelstränge von Amplifikaten | |
DE10010282B4 (de) | Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben | |
WO2002083943A2 (de) | Mikroarray-verfahren zur anreicherung von dna-fragmenten aus komplexen mischungen | |
EP1292711B1 (de) | Verfahren zur hochparallelen analyse von polymorphismen | |
DE10128508A1 (de) | Verfahren und Nukleinsäuren für die Differenzierung von Prostata-Tumoren | |
WO2002036814A2 (de) | Diagnose von mit cdk4 assoziierten krankheiten durch bestimmung des methylierungszustandes des cdk4 | |
EP1320632B1 (de) | Verfahren zur altersbestimmung von individuen | |
EP1339873B1 (de) | Diagnose von mit humos assoziierten krankheiten | |
DE10013847A1 (de) | Oligonukleotide oder PNA-Oligomere und Verfahren zur parallelen Detektion des Methylierungszustandes genomischer DNA | |
WO2004022779A2 (de) | Verfahren zum nachweis von nukleinsäuresequenzen mittels spaltbarer sondenmoleküle | |
DE10044543C2 (de) | Verfahren zur Bestimmung des Methylierungsgrades von bestimmten Cytosinen in genomischer DNA im Sequenzkontext 5'-CpG-3' | |
EP1451359A2 (de) | Verfahren und integrierte vorrichtung zum nachweis von cytosinmethylierungen | |
DE20121967U1 (de) | Nukleinsäuren für die Diagnose von Verhaltensstörungen, neurologischen Erkrankungen und Krebs | |
DE20121965U1 (de) | Nukleinsäuren für die Diagnose von mit DNA Addukten assoziierten Krankheiten | |
DE20121974U1 (de) | Nukleinsäuren für die Diagnose von mit DNA Replikation assoziierten Krankheiten | |
DE20121964U1 (de) | Nukleinsäuren für die Diagnose von mit dem Metabolismus assoziierten Krankheiten | |
DE20121979U1 (de) | Nukleinsäuren für die Diagnose von mit der Zellsignalisierung assoziierten Krankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001923891 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001923891 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10257017 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001923891 Country of ref document: EP |